-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2023-503868-16-00
5
2022-02-14
Small-Cell Lung Cancer (SCLC)
-
2023-508242-18-00
6
2021-12-21
Crohn's disease
-
2023-503674-20-00
5
2021-12-17
Unresectable, locally advanced, or metastatic Non-Small Cell Lung Canc
-
2023-506518-33-00
5
2021-11-10
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-503568-18-00
5
2021-04-13
Early human epidermal growth factor receptor 2 (HER2) positive breast
-
2023-507475-21-00
10
2021-01-18
Lung Cancer, Non-Small Cell
-
2023-507263-19-00
5
2020-12-23
Advanced Non-Small Cell Lung Cancer
-
2023-506911-16-00
5
2020-12-04
ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTAT
-
2022-502746-27-00
5
2020-08-21
Endometrial Cancer
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
-
2023-507902-15-00
4
2019-03-26
Non-Small Cell Lung Cancer
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2023-509602-29-00
5
2019-02-11
Patients with Limited Stage Small-Cell Lung Cancer (LS-SCLC)
-
2023-506921-12-00
5
2018-12-27
ER+/HER2- Breast Cancer
-
2022-501966-23-00
5
2018-09-11
Resected High-Risk Stage II Melanoma
-
2023-510358-17-00
5
2018-09-01
Hyperglycemia in critically ill patients (stress hyperglycemia)
-
2024-511890-30-03
6
2018-06-26
Subfertility
-
2023-503469-49-00
5
2018-04-19
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
-
2022-502798-40-00
5
2017-07-31
Patients with resected colon carcinoma
-
2023-509671-17-00
5
2017-07-12
Breast Cancer
-
2022-500630-29-00
5
2016-05-06
Subjects with High Risk Invasive Urothelial Carcinoma
-
2023-505096-68-00
4
2025-01-14
Preclinical Alzheimer’s Disease